Statements (27)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:chemical_compound
antidepressant |
| gptkbp:administered_via |
oral route
|
| gptkbp:ATCCode |
N06AA22
|
| gptkbp:CASNumber |
15686-37-0
|
| gptkbp:chemicalClass |
dibenzocycloheptene
|
| gptkbp:developedBy |
gptkb:Japan
|
| gptkbp:discoveredBy |
1970s
|
| gptkbp:eliminationHalfLife |
8.1 hours
|
| gptkbp:hasMolecularFormula |
C19H21N
|
| gptkbp:hasSMILES |
CNCCC=C1C2=CC=CC=C2CCC3=CC=CC=C13
|
| gptkbp:hasUNII |
6Z5B6HVF6O
|
| https://www.w3.org/2000/01/rdf-schema#label |
Setiptiline
|
| gptkbp:is_not_approved_in |
gptkb:Europe
gptkb:United_States |
| gptkbp:IUPACName |
3-(10,11-dihydro-5H-dibenzo[a,d][7]annulen-5-ylidene)-N-methylpropan-1-amine
|
| gptkbp:legal_status_in_Japan |
prescription only
|
| gptkbp:marketedAs |
Tecipul
|
| gptkbp:PubChem_CID |
28613
30843 |
| gptkbp:sideEffect |
constipation
weight gain drowsiness dry mouth |
| gptkbp:usedFor |
gptkb:depression
|
| gptkbp:bfsParent |
gptkb:Antidepressants
|
| gptkbp:bfsLayer |
6
|